Novartis Hit With $1M Ruling In Aredia, Zometa Suit

Law360, New York (November 24, 2010, 5:02 PM EST) -- A North Carolina court hit Novartis Pharmaceuticals Corp. with a $1.2 million judgment Monday after jurors found the company failed to warn a woman's doctor the bone drugs Aredia and Zometa could cause a severe jaw disease known as osteonecrosis.

The jury in the U.S. District Court for the Middle District of North Carolina issued its verdict Nov. 22, initially levying punitive damages of $12.6 million and compensatory damages of $287,000. State law limits punitive damages to three times the compensatory damages, so Judge James A....
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.